NP / PA
Reevas, Brent
Reevas, Brent was paid $199K by Medicaid between Jun 2020 and Jan 2022, across 13 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoREEVAS, BRENT
PALOS HEIGHTS, IL 60463
PALOS HEIGHTS, IL 60463
33aNPI1750921631assigned 01/08/2020
33bProvider typeNurse Practitioner
28Total paid$199K
24GClaims4,393
24DCodes billed13
24AFirst – last monthJun 2020 – Jan 2022
Compared with peers
Next to other Nurse Practitioner providers in Illinois
Rank by total paid#154 of 1,687
Median peer was paid$22K
This provider vs. median9.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,110 | $50K | |
| 2021 | 3,078 | $140K | |
| 2022 | 205 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 981 | 741 | $66K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 1,074 | 842 | $46K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9.9% | 255 | 218 | $20K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 9.7% | 473 | 433 | $19K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.1% | 402 | 322 | $18K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 4.8% | 280 | 257 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.6% | 306 | 267 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 109 | 101 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 50 | 45 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 156 | 139 | $2K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.1% | 44 | 35 | $2K |
| 81025 | <1% | 135 | 96 | $669.25 |
1 more codes
| 81002 | <1% | 128 | $332.45 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.